Genmab Market Cap

Genmab has a market cap or net worth of €16.76 billion as of December 5, 2025. Its market cap has increased by 36.19% in one year.

Market Cap

16.76B

Enterprise Value

13.97B

Revenue

3.28B

Ranking

n/a

PE Ratio

12.42

Stock Price

€270.80

Market Cap Chart

Since October 18, 2000, Genmab's market cap has increased from 485.53M to 16.76B, an increase of 3,351.66%. That is a compound annual growth rate of 15.12%.

Market Cap History

Date	Market Cap	% Change
Dec 5, 2025	16.76B	31.78%
Dec 30, 2024	12.72B	-32.67%
Dec 29, 2023	18.89B	-26.92%
Dec 30, 2022	25.84B	11.67%
Dec 30, 2021	23.14B	6.90%
Dec 30, 2020	21.65B	67.74%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
SAP SE	240.49B
Siemens Aktiengesellschaft	177.09B
Allianz SE	138.86B
Deutsche Telekom AG	129.48B
Siemens Energy AG	97.17B
Rheinmetall AG	69.69B
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München	68.36B
Deutsche Bank Aktiengesellschaft	58.36B

Market Cap Rankings